Mannitol for acute stroke

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Bereczki, Dániel ^a   Liu, M ^b   Do Prado, G F ^b   Fekete, I ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b NONE

Author keywords

Acute disease; Brain edema drug therapy ; Brain ischemia *drug therapy ; Cerebral hemorrhage *drug therapy ; Diuretics, osmotic adverse effects; *therapeutic use ; Mannitol adverse effects; *therapeutic use

Indexed keywords

MANNITOL; OSMOTIC AGENT; SCAVENGER;

ACUTE DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; DATA BASE; DEATH; DISABILITY; FATALITY; HUMAN; HYPONATREMIA; MEDLINE; OUTCOMES RESEARCH; REVIEW; STROKE;

EID: 38349146259     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001153.pub2     Document Type: Review

References (78)

1. Kalita 2004a {published data only} Kalita J, Misra UK, Ranjan P, Pradhan PK, Das BK. Effect of mannitol on regional cerebral blood flow in patients with intracerebral hemorrhage. Journal of the Neurological Sciences 2004;224(1-2):19-22.
2. Misra 2005 {published data only} Misra UK, Kalita J, Ranjan P, Mandal SK. Mannitol in intracerebral hemorrhage: a randomized controlled study. Journal of the Neurological Sciences 2005;234(1-2):41-5.
3. Santambrogio 1978 {published data only} Santambrogio S, Martinotti R, Sardella F, Porro F, Randazzo A. Is there a real treatment for stroke? Clinical and statistical comparison of different treatments in 300 patients. Stroke 1978;9:130-2.
4. Battison 2005 Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Critical Care Medicine 2005;33(1):196-202.
5. Cruz 2002 Cruz J, Minoja G, Okuchi K. Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial. Neurosurgery 2002;51(3):628-37.
6. Cruz 2004 Cruz J, Minoja G, Okuchi K, Facco E. Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial. Journal of Neurosurgery 2004;100(3):376-83.
7. Freeman 1978 Freeman J, Tappin J, Karat ABA, Meecham J. Dexamethasone in acute stroke. BMJ 1978;2:1500.
8. Hooshmand 1972 Hooshmand H, Quinn JC, Houff SA. Cerebrospinal fluid pressure changes with chemotherapy for intracerebral hemorrhage. Neurology 1972;22(1):56-61.
9. Jiang 1993 Jiang DB, Han ZY, Wang DQ. Insulin and mannitol in treatment of acute cerebral infarction. Chinese Journal of Neurology & Psychiatry 1993;26:84-7.
10. Kong 1996 Kong YN. Free radical scavanger in the treatment of cerebral infarction (40 cases). Journal of Clinical Neurology 1996;9:174-5.
11. Shi 2000 Shi Y, Kong X. Influence of mannitol on early enlargement of hematoma in hypertensive cerebral hemorrhage. Chinese Medical Journal 2000;80(11):849-51.
12. Wu 1993 Wu SH. Mannitol in the treatment of acute cerebral infarction (analysis of 50 cases). Journal of Stroke and Neurological Diseases 1993;10(3):177-8.
13. Xie 1992 Xie P, Sen X, Hu Y. Low dose mannitol in the treatment of acute stroke. Journal of Clinical Neurology 1992;5(1):52-61.
14. Xie 1996 Xie P, Sen X. A prospective study of small amount of mannitol and insulin in the treatment of acute cerebral infarction. Journal of Brain and Neurological Diseases 1996;4:21-3.
15. Zhao 1987 Zhao PX. Clinical study on the effect of 20% mannitol in treating cerebral thrombosis. Chung Hua Shen Ching Ching Shen Ko Tsa Chih 1987;20(3):169-72.
16. Zhen 1996 Zhen JG. Clinical effectiveness of acupuncture using 'Xian-Nau-Kai-Xiau' technique for acute cerebral haemorrhage. Tianjing Traditional Medical College Bulletin 1996;4:21-3.
17. Adams 1996 Adams HP, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, et al.Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 1996;94:1167-74.
18. Adams 2003 Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, et al.Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34(4):1056-83.
19. Andrews 1993 Andrews RJ, Bringas JR, Muto RP. Effects of mannitol on cerebral blood flow, blood pressure, blood viscosity, hematocrit, sodium, and potassium. Surgical Neurology 1993;39:218-22.
20. Bereczki 2003 Bereczki D, Mihalka L, Szatmari S, Fekete K, Di Cesar D, Fulesdi B, et al.Mannitol use in acute stroke: case fatality at 30 days and 1 year. Stroke 2003;34(7):1730-5.
21. Brient 1965 Brient BW, Zimmerman JM, King TC. The effect of prolonged hypothermia and mannitol infusion upon the neurologic sequelae of total cerebral ischemia. Surgical Forum 1965;16:407-8.
22. Broderick 1999 Broderick JP, Adams HP Jr, Barsan W, Feinberg W, Feldmann E, Grotta J, et al.Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999;30(4):905-15.
23. Canalese 1982 Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 1982;23:625-9.
24. Candelise 1974 Candelise L, Colombo A, Spinnler H. Anti-oedema treatment of completed stroke. Lancet 1974;861:806.
25. Candelise 1975 Candelise L, Colombo A, Spinnler H. Therapy against brain swelling in stroke patients. A retrospective clinical study on 227 patients. Stroke 1975;6:353-6.
26. CAST 1997 CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997;349:1641-9.
27. Castro 1997 Castro AA, Clark OAC, Atallah AN. Optimal search strategy for clinical trials in the Latin American Caribbean Health Science Literature Database (LILACS). São Paulo Medical Journal (Revista Paulista de Medicina) 1997;115:1423-6.
28. Chen 1997 Chen ZM, Sandercock P, Xie JX, Peto R, Collins R, Liu LS. Hospital management of acute ischaemic stroke in China. Journal of Stroke and Cerebrovascular Diseases 1997;6:361-7.
29. Davis 1994 Davis M, Lucatorto M. Mannitol revisited. Journal of Neuroscience Nursing 1994;26:170-4.
30. Donato 1994 Donato T, Shapira Y, Artru A, Powers K. Effect of mannitol on cerebrospinal fluid dynamics and brain tissue edema. Anesthesia and Analgesia 1994;78:58-66.
31. Ebisu 1997 Ebisu T, Tanaka C, Umeda M, Kitamura M, Fukunaga M, Aoki I, et al.Hemorrhagic and nonhemorrhagic stroke: diagnosis with diffusion-weighted and T2-weighted echo-planar MR imaging. Radiology 1997;203:823-8.
32. EUSI 2003 Hacke W, Kaste M, Bogousslavsky J, Brainin M, Chamorro A, Lees K, et al.European Stroke Initiative recommendations for stroke management: update 2003. Cerebrovascular Diseases 2003;16(4):311- 37.
33. Gigliuto 1991 Gigliuto CM, Stone KE, Algus M. The use of mannitol in intracerebral bleeds in the medical ICU. New Jersey Medicine 1991;88:48-51.
34. Haass 1987 Haass A, Kloss R, Brenner M, Hamann G, Harms M, Schimrigk K. Intracranial pressure-controlled treatment of brain edema with glycerin and sorbitol in intracerebral hemorrhage. Nervenarzt 1987;58:22-9.
35. IST 1997 International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997;349:1569-81.
36. James 1977 James HE, Langfitt TW, Kumar VS, Ghostine SY. Treatment of intracranial hypertension. Analysis of 105 consecutive, continuous recordings of intracranial pressure. Acta Neurochirurgica 1977;36:189-200.
37. James 1980 James HE. Methodology for the control of intracranial pressure with hypertonic mannitol. Acta Neurochirurgica 1980;51:161-72.
38. Kalita 2004b Kalita J, Misra UK, Ranjan P. Prescribing pattern of antiedema therapy in stroke by neurologists and general physicians. Neurology India 2004;52(2):191-3.
39. Karibe 1995 Karibe H, Zarow GJ, Weinstein PR. Use of mild intra-ischemic hypothermia versusmannitol to reduce infarct size after temporary middle cerebral artery occlusion in rats. Journal of Neurosurgery 1995;83:93-8.
40. Katzman 1977 Katzman R, Clasen R, Klatzo I, Meyer JS, Pappius HM, Waltz AG. Report of Joint Committee for Stroke Resources: IV. Brain edema in stroke. Stroke 1977;8:512-40.
41. Kaufmann 1992 Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral edema by multiple dose mannitol. Journal of Neurosurgery 1992;77:584-9.
42. Kobayashi 1994 Kobayashi H, Ide H, Kodera T, Handa Y, Kabuto M, Kubota T, et al.Effect of mannitol on focal cerebral ischemia evaluated by magnetic resonance imaging. Acta Neurochirurgica. Supplementum 1994;60:228-30.
43. LILACS 1997 BIREME-OPS/OMS. Literatura Latinoamericana y del Caribe en Ciencias de la Salud (LILACS). 29a. BIREME-OPS/OMS, September 1997.
44. Luvisotto 1996 Luvisotto TL, Auer RN, Sutherland GR. The effect of mannitol on experimental cerebral ischemia, revisited. Neurosurgery 1996;38:131-8.
45. Manno 1999 Manno EM, Adams RE, Derdeyn CP, Powers WJ, Diringer MN. The effects of mannitol on cerebral edema after large hemispheric cerebral infarct. Neurology 1999;52(3):583-7.
46. Mayer 2005 Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al.Recombinant activated factor VII for acute intracerebral hemorrhage. New England Journal of Medicine 2005;352:777-85.
47. McNeill 1985 McNeill IY. Hypersensitivity reaction to mannitol. Drug Intelligence & Clinical Pharmacy 1985;19:552-3.
48. Mendelow 2005 Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al.Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005;365:387-97.
49. Mizoi 1986 Mizoi K, Suzuki J, Imaizumi S, Yoshimoto T. Development of new cerebral protective agents: the free radical scavengers. Neurological Research 1986;8:75-80.
50. Oken 1994 Oken DE. Renal and extrarenal considerations in high-dose mannitol therapy. Renal Failure 1994;16:147-59.
51. Onar 1997 Onar M, Arik Z. The evaluation of mannitol therapy in acute ischemic stroke patients by serial somatosensory evoked potentias. Electromyography and Clinical Neurophysiology 1997;37:213-8.
52. Paczynski 1997 Paczynski RP, He YY, Diringer MN, Hsu CY. Multiple-dose mannitol reduces brain water content in a rat model of cortical infarction. Stroke 1997;28:1437-43.
53. Pena 1982 Pena H, Gaines C, Suess D, Crowell RM, Waggener JD, DeGirolami U. Effect of mannitol on experimental focal ischemia in awake monkeys. Neurosurgery 1982;11:477-81.
54. Poungvarin 1987 Poungvarin N, Bhoopat W, Viriyavejakul A, Rodprasert P, Buranasiri P, Sukondhabhant S, et al.Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. New England Journal of Medicine 1987;316:1229-33.
55. Prasad 1998 Prasad K, Shrivastava A. Surgical treatment in patients with primary supratentorial intracerebral haemorrhage. Cochrane Database of Systematic Reviews 1998, Issue 2.
56. Qizilbash 2002 Qizilbash N, Lewington SL, Lopez-Arrieta JM. Corticosteroids for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2002, Issue 3.Art. No.: CD000064. DOI:10.1002/14651858.CD000064.
57. Rabetoy 1993 Rabetoy GM, Fredericks MR, Hostettler CF. Where the kidney is concerned, how much mannitol is too much?. Annals of Pharmacotherapy 1993;27:25-8.
58. Rabinstein 2006 Rabinstein AA. Treatment of cerebral edema. Neurologist 2006;12:59-73.
59. Reyes 1981 de los Reyes RA, Ausman JI, Diaz FG. Agents for cerebral edema. Clinical Neurosurgery 1981;28:98-107.
60. Righetti 2004 Righetti E, Celani MG, Cantisani T, Sterzi R, Boysen G, Ricci S. Glycerol for acute stroke. Cochrane Database of Systematic Reviews 2004, Issue 2.Art. No.: CD000096. DOI:10.1002/14651858.CD000096. pub2.
61. Schierhout 1998 Schierhout G, Roberts I. Mannitol in acute traumatic brain injury. Cochrane Database of Systematic Reviews 1998, Issue 1.
62. Schlaug 1997 Schlaug G, Siewert B, Benfield A, Edelman RR, Warach S. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology 1997;49:113-9.
63. Schwab 1996 Schwab S, Schellinger P, Aschoff A, Albert F, Spranger M, Hacke W. Epidural cerebrospinal fluid pressure measurement and therapy of intracranial hypertension in 'malignant' middle cerebral artery infarct. Nervenarzt 1996;67:659-66.
64. Schwarz 1998 Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 1998;29(8):1550-5.
65. Slivka 1990 Slivka A, Silbersweig D, Pulsinelli W. Carnitine treatment for stroke in rats. Stroke 1990;21:808-11.
66. Steiner 2001 Steiner T, Pilz J, Schellinger P, Wirtz R, Friederichs V, Aschoff A, et al.Multimodal online monitoring in middle cerebral artery territory stroke. Stroke 2001;32(11):2500-6.
67. Suzuki 1980 Suzuki J, Tanaka S, Yoshimoto T. Recirculation in the acute period of cerebral infarction: brain swelling and its suppression using mannitol. Surgical Neurology 1980;14:467-72.
68. Treib 1998 Treib J, Becker SC, Grauer M, Haass A. Transcranial Doppler monitoring of intracranial pressure therapy with mannitol, sorbitol and glycerol in patients with acute stroke. European Neurology 1998;40(4):212-9.
69. Troupp 1971 Troupp H, Valtonen S, Vapalahti M. Intraventricular pressure after administration of dehydrating agents to severely brain-injured patients: is there a rebound phenomenon?. Acta Neurochirurgica 1971;24:89-95.
70. Videen 2001 Videen TO, Zazulia AR, Manno EM, Derdeyn CP, Adams RE, Diringer MN, et al.Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke. Neurology 2001;57(11):2120-2.
71. Warach 1995 Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Annals of Neurology 1995;37:231-41.
72. Wardlaw 2003 Wardlaw JM, del Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2003, Issue 3.Art. No.: CD000213. DOI:10.1002/14651858.CD000213.
73. Weaver 1987 Weaver A, Sica DA. Mannitol-induced acute renal failure. Nephron 1987;45:233-5.
74. Winkler 1995 Winkler SR, Munoz-Ruiz L. Mechanism of action of mannitol. Surgical Neurology 1995;43:59.
75. Woster 1990 Woster PS, LeBlanc KL. Management of elevated intracranial pressure. Clinical Pharmacy 1990;9:762-72.
76. Yu 1992 Yu YL, Kumana CR, Lauder IJ, Cheung YK, Chan FL, Kou M, et al.Treatment of acute cerebral hemorrhage with intravenous glycerol. A double-blind, placebo-controlled, randomized trial. Stroke 1992;23:967-71.
77. Bereczki 2000 Bereczki D, Liu M, Prado GF, Fekete I. Cochrane report: a systematic review of mannitol therapy for acute ischemic stroke and cerebral parenchymal hemorrhage. Stroke 2000;31:2719-22.
78. Bereczki 2001 Bereczki D, Liu M, Prado GF, Fekete I. Mannitol for acute stroke. Cochrane Database of Systematic Reviews 2001, Issue 1.Art. No.: CD001153. DOI:10.1002/14651858.CD001153.pub2.